Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

Healthcare innovation in Northern France

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Lots of buzz online about the Hauts-de-France Region

The Hauts-de-France Region has been the subject of a digital communication campaign aimed at European business leaders since mid-July. After ten weeks of broadcasting on social networks, the time has come to...

Maroquinerie Thomas is investing €6M in a factory in Arras

Leading European luxury goods subcontractor Maroquinerie Thomas has chosen Hauts-de-France for its future manufacturing site, with plans to invest €6M and create more than 250 jobs within the next four years....

All news